RankAlpha logo
Back to Rankings

IMNN

ImunonA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
IMNN vs peer average
82/100
IMNN vs. peer average (A vs. C)
Grade spread
A 2 · B 1 · C 3 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

CNTX is the first available peer comparator.

Context Therapeutics' CTIM-76 provides an ovarian-cancer clinical reference, but its Phase 1 bispecific-antibody study treats heavily pretreated platinum-resistant patients. It is neither a stage-matched nor a frontline valuation peer for IMNN-001. [Context company update](https://ir.contexttherapeutics.com/news-releases/news-release-details/context-therapeutics-announces-positive-interim-efficacy-and).

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCNTXContext Therapeutics
IMNN
Imunon
CNTX
Context Therapeutics
Grade
A
A
Momentum
93
99
Value
41
58
Sentiment
84
77
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare top peers (up to 3)

Grade position vs CNTX

IMNN / CNTX
Grade Position
Above peers
IMNN vs. peer average (A vs. C)
82/100
Momentum
93
CNTX
Value
41
CNTX
Sentiment
84
IMNN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IMNN
1
CNTX
CNTX
A
100/100
Even
2
GNLX
GNLX
B
80/100
-1
3
TRAW
Traws Pharma Inc Common
C
60/100
-2
4
JAGX
Jaguar Health Inc Common
A
100/100
Even
5
NCNA
NuCana plc ADR
D
40/100
-3
CNTX is the first peer returned for this comparison set.